Cocaine-related ischemic priapism. Systematic review and presentation of a single center series.

Introduction: Ischemic priapism is a medical emergency that, if not treated, could lead to permanent erectile dysfunction. The association between cocaine and priapism is well-known; however, data on patient characteristics, treatment, and outcomes is missing. This work aimed to answer the research question: What are the characteristics, management strategies, and erectile prognosis of patients consuming cocaine and presenting with priapism?

Methods: We conducted a systematic review according to PRISMA guidelines and described our case series.

European Association of Urology biochemical recurrence risk groups after radical prostatectomy: External validation and identification of independent risk factors for progression and death.

Background: The EAU proposed a progression and death risk classification in patients with biochemical recurrence after radical prostatectomy (PR).

Objective: To validate the EAU BCR-risk classification in our setting and to find factors related to progression and death.

Material And Methods: Multicenter, retrospective, observational study including 2140 patients underwent RP between 2011 and 2015.

Single-port retroperitoneoscopic partial nephrectomy: Initial description and standardisation of technique.

Introduction: Minimally invasive surgery has been established as the gold standard for the treatment of localised renal tumours. A retroperitoneal approach is a feasible option with advantages in posterior tumours and patients with previous abdominal surgeries. In this context, single-port retroperitoneoscopic partial nephrectomy (SPOR-PN) has not been widely explored and developed.

Anosmia and dysgeusia in COVID-19: A systematic review.

This systematic review had three aims: i) to determine the frequency of anosmia (or other smell disorders) and dysgeusia (or other taste disorders) in COVID-19 patients; ii) to determine whether anosmia or dysgeusia are independently associated with COVID-19 diagnosis; and iii) to determine whether anosmia or dysgeusia are prognostic factors for impaired outcomes among COVID-19 patients. On April 20 , 2020, we search MEDLINE, Embase, Global Health, Scopus, Web of Science and MedXriv. We used terms related to COVID-19, smell and taste disorders.